Nuveen, LLC Tenaya Therapeutics, Inc. Call Options Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TNYA
# of Institutions
97Shares Held
41.9MCall Options Held
74.3KPut Options Held
192K-
Column Group LLC San Francisco, CA9.4MShares$4.51 Million24.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$3.23 Million0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$1.96 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$1.96 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$1.08 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $19.9M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...